Crispr Therapeutics Ag (CRSP) Cash Conversion Ratio & History | Stock Alarm

Demo Sign up Log In

Crispr Therapeutics Ag · Cash Conversion Ratio

CRSP Cash Conversion Ratio

Current (TTM)0.83×retrievedOct 20, 2026

CRSP Cash Conversion Ratio (-2.26× → 0.83×)

Latest values, visible window

High-resolution chart · PNG

CRSP cash conversion ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Cash Conversion Ratio — Annual fiscal periods
Period ending	Cash Conversion Ratio
Dec 31, 2025	0.5948×
Dec 31, 2024	0.395×
Dec 31, 2023	1.7567×
Dec 31, 2022	0.8197×
Dec 31, 2021	1.2108×
Dec 31, 2020	0.7359×
Dec 31, 2019	0.7477×
Dec 31, 2018	0.6001×
Dec 31, 2017	1.1398×
Dec 31, 2016	2.5138×
Dec 31, 2015	-2.2562×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.